Using Ultrasound to Predict Response to Intraarticular Corticosteroids in Knee Osteoarthritis
Launched by UNIVERSITY OF CALIFORNIA, SAN DIEGO · Sep 3, 2008
Trial Information
Current as of September 05, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • knee pain
- • diagnosis of osteoarthritis in affected knee
- Exclusion Criteria:
- • intraarticular corticosteroids in affected knee within past three months
- • primary inflammatory connective tissue disease (ie rheumatoid arthritis)
- • currently taking oral corticosteroids
About University Of California, San Diego
The University of California, San Diego (UCSD) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust focus on translational medicine, UCSD leverages its interdisciplinary approach to explore groundbreaking therapies and interventions across a wide range of medical fields. The university's state-of-the-art facilities and collaboration with top-tier faculty and researchers ensure a comprehensive and ethical framework for conducting clinical trials, ultimately aiming to enhance patient outcomes and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
La Jolla, California, United States
La Jolla, California, United States
Patients applied
Trial Officials
Kenneth Kalunian, MD
Principal Investigator
University of California, San Diego
Anna Quan, MD
Study Chair
San Diego VA Hospital
Michal Kalli Hose, MD
Study Director
San Diego VA Hospital
Jeannie Chao, MD
Study Director
University of California, San Diego
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials